The takeaway
Ovintiv Inc shows a slight seasonal lean over 10 years of data — strongest in July (+3.2%) and softest in April (+12.1%).
Right now
In July, the stock has risen 70% of years, averaging +3.2%, about +1.0 pts better than the S&P 500.
The full picture
Ovintiv Inc's most dependable month has been July, higher in 7 of 10 years; April has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in April (+10.4 pts); it has trailed the market most in March (−3.2 pts).
“vs S&P” is Ovintiv Inc’s average for a month minus the S&P 500’s average for that same month — isolating Ovintiv Inc’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, July has closed higher 60% of the time versus 70% across the last 10 years — the pattern is holding.
Figures are the typical (median) July return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Dependability is the through-line here. July stands out, higher in 7 of 10 Julys, but it heads a clutch of months that pull the year reliably upward.
Its average (+3.2%) and median (+3.8%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. That reliability comes with real swings, mind — even July ranges by 12.4% from year to year, so any single year can land far from the average. Crucially, the gain is the stock's own rather than a rising tide's: July has cleared the S&P 500 by +1.0 points above the index. Some of that is a strong month market-wide, mind — July rises for about 61% of stocks — so the tendency is real if not unique.
A few other months pull their weight: January, March, and May have also closed higher more often than not. At the other end of the calendar, April is the year's low point, though even there the stock has stayed positive on average (+12.1%), a sign every month leans up, and the edge isn't year-round — the stock has trailed the S&P 500 in March, October, and January. Its roughest month on record was a −75.6% March in 2020 — a reminder of how hard even a seasonal name can fall.
Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
The takeaway is less about when to buy than what to expect: July aside, the stock's months offer little reliable tilt. With returns that swing hard year to year, the signal is best held loosely.
Short answers on the stock's best month (July), its worst (April), and whether it really trades seasonally.
Only mildly. The stock's months are fairly even — July is the firmest (+3.2%) and April the softest (+12.1%), a narrow spread that points to weak seasonality rather than a strong calendar effect.
July has been the strongest, averaging +3.2% and closing higher in 7 of 10 years since 2016.
It's the weakest month, but it has still averaged a small gain (+12.1%) — quiet rather than genuinely bad.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade